At Ferozsons, it's your health before anything else! We strive to attain market leadership by putti fields. The new wing will be operational in early 2013.
The Corporate History of the Ferozsons Group began in 1894, when its Founder Maulvi Ferozuddin Khan established the Ferozsons publishing house. From the outset, our founder’s corporate vision involved playing a meaningful role in the education and health of the underprivileged population of the sub-continent. Consequently, Ferozsons Laboratories Limited was created in 1954 as one of the first pharmaceutical manufacturing facilities in the fledgling state of Pakistan. The company commenced operations in 1956, and in 1960 became the first Pakistani pharmaceutical company to be lister on the Karachi Stock Exchange. We have a consistent track record of financial performance, and are a 6-time recipient of the Karachi Stock Exchange's 'KSE Top 25 Companies Award.'
Through our range of branded generics and in-licensed products , we have attained market leadership in the areas of cardiology , oncology, gastroenterology, dermatology and anti-infective markets in the Pakistan. These products are now being exported to markets in Asia and Africa, and we are actively seeking export opportunities in other markets. Ferozsons is the Pakistan marketing and distribution partner for the Boston Scientific Corporation, USA for its range of cardiac and peripheral products and interventional devices. This partnership will allow us to further strengthen our channels in cardiology , oncology, and G.I. We offer principals an excellent manufacturing, marketing and distribution platform for launching their products in the Pakistan market. Our cGMP compliant production facility in Nowshera is ISO 9001 certified and we are fully equipped with state of the art manufacturing and testing equipment. The facility consists of independent sections, each with its own dedicated air handling system to avoid cross-contamination between different classes of drugs being manufactured. Our production capabilities include the manufacturing of tablets, capsules, syrups, suspensions, creams and ointments. Our facility control laboratory is among the best equipped in the industry and possesses Malver Particle Size Analyzers, High Performance Liquid Chromatographs (HPLC), Gas Chromatograph (GC), Fourier Transfer-IR Spectrophotometer and UV-Visible spectrometers, in addition to dissolution, disintergration, hardness and friability testers. In 2012, the Company undertook a major expansion in its manufacturing, adding a new production wing for the production of solid dosage forms.
13/03/2026
On World Obesity Day, our teams at Ferozsons Laboratories Limited and BF Biosciences Limited came together to reflect on this year’s theme: 8 Billion Reasons to Act on Obesity.
Through a series of engaging office activities, our employees participated in BMI screenings and one-on-one consultations with a clinical nutritionist.
As Childhood Obesity is increasing rapidly, a poster competition highlighting childhood obesity awareness was held for employees and their loved ones.
A special highlight of the day was a live podcast with Prof. Dr. Maaz ul Hassan (Consultant Laparoscopic, General and Obesity surgeon), Head of Department, Shalamar Hospital. The open platform led to healthy discussions on the realities and solutions around obesity.
Together, we continue to build awareness and encourage healthier choices — because every action counts in changing the story of obesity.
We all have our reasons to change the story of obesity. What’s yours?
12/03/2026
Ferozsons Laboratories Limited & BF Biosciences Limited successfully convened high-level , bringing together leading , , and Consultant Physicians.
The forum enabled deep, evidence-based dialogue around /GIP, enriched by real-world and robust peer discussion on of the WHY, WHERE, and HOW of .
The deliberations strongly emphasised the importance of a paradigm—where is complemented by dietary optimisation and structured physical activity—to achieve sustainable .
12/03/2026
Did you know? affects 1 in 10 people worldwide.
Environmental challenges such as air pollution, heat stress, dehydration, and extreme weather events increase the risk of and speed up its progression. At the same time, treatments for end-stage kidney disease, particularly , require large amounts of water, energy, and single-use plastics, placing an added burden on the environment.
This , lets prioritize prevention, , and greener therapies, so we can protect both our kidney health and our planet.
Ferozsons Laboratories Limited extends warm wishes to the people of on the occasion of . May this day celebrate freedom, resilience, and continued progress for the nation.
08/03/2026
On International Women’s Day, we celebrate the contributions, resilience, and achievements of women worldwide.
Because when we give respect, opportunity, and encouragement, we all gain.
06/03/2026
On , we celebrate and thank our employees whose dedication drives our purpose and our commitment to .
BF Biosciences Limited
06/03/2026
Ferozsons Laboratories Limited & BF Biosciences extend warm wishes to the people of on the occasion of . May this day celebrate freedom, resilience, and continued progress for the nation.
06/03/2026
Pakistan carries one of the highest burdens of in the world — making awareness, early screening, and timely counselling more critical than ever.
Through a joint initiative by Ferozsons Laboratories Limited and the Foundation, a hepatitis B & C screening and counselling camp was successfully carried out in Syedanwala Village to help identify cases early and guide communities toward care.
and counselling at the community level can create a long-term meaningful impact.
Together, let’s join hands for a Hepatitis-Free Pakistan by 2030.
03/03/2026
On , we confront a growing global health crisis that demands urgent and collective action - .
Today, over 1 billion people worldwide are living with obesity. In less than a decade, by 2035, nearly half of the global population — around 4 billion people — are expected to be living with overweight and obesity.
Obesity is not just about weight. It is a complex, chronic disease linked to diabetes, heart disease, liver disorders, and other metabolic complications. This affects everyone, and the story really starts quite early. Childhood obesity is rising rapidly. As a result, many children have also started showing early signs of diabetes.
The time to act is now — through , , early intervention, and evidence-based care. Together, we can change the story.
Slim Possible
28/02/2026
As part of February 2026, our teams at Limited and BF Biosciences Limited came together for a Fire & Burn Safety Program under our initiative - (Shield Against Fire Effects)
The program began with an insightful talk by Dr. Mustehsan Bashir , Professor and Chairperson Burn & Reconstructive Surgery Department, Mayo Burn Centre,
Mayo Hospital, Lahore, who shared expert guidance on immediate burn care and clinical management to minimise long-term impact and improve patient outcomes.
A Fire Management awareness session and drill conducted by , equipped our employees with practical, real-time emergency response skills and confidence in rescue protocols.
Through awareness and preparedness, we continue fostering a safer workplace — because protecting lives begins with knowledge and action.
25/02/2026
The future of marketing will be defined by how effectively we combine with to create lasting impact in healthcare.
As part of our capability-building roadmap, Ferozsons Laboratories Limited and BF Biosciences launched AI Mastery: — a two-day strategic training program for our Marketing Teams, designed to embed AI-enabled thinking into brand planning and ex*****on.
The training was conducted by leading expert Mr. Jazib Zahir, Director, LCE - LUMS Centre for Entrepreneurship and LUMSx.
This initiative is a key step for our teams to:
• Reduce time spent on routine activities through intelligent automation
• Improve decision quality using AI-supported insights
• Translate data into clearer priorities
• Develop practical, AI-enhanced brand plans ready for ex*****on
28/11/2025
This , we turned awareness into action!
From checks and screenings to activities and expert-led guidance session — our teams at Ferozsons Laboratories Limited & BF Biosciences Limited came together to own their wellbeing at workplace.
Dr. Prof. , leading , elevated the event with an engaging and interactive session with the employees on practical lifestyle changes for a healthier workplace.
Together, we aim to turn the tide against diabetes — one habit at a time.
Be the first to know and let us send you an email when Ferozsons Laboratories Limited posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
The foundations of the Ferozsons business group were laid in 1894 by Maulvi Ferozuddin Khan, who founded the Ferozsons publishing house. From the outset, the group’s corporate vision involved playing a meaningful role in the education and health of the underprivileged population of the sub-continent. Ferozsons Laboratories Limited was thus established in 1956 as one of the first Pharmaceutical manufacturing companies in Pakistan, and has now entered its seventh decade of serving the cause of health and well- being in Pakistan and a growing number of international markets.
In 1960, we became the first Pakistani pharmaceutical company to be listed on the Karachi Stock Exchange (KSE) Limited, and have a consistent track record of delivering on our financial objectives. The company is a multiple-time recipient of the KSE Top 25 Companies Award.
Ferozsons set the standards for the strict adherence to Global Standards of Quality Control and Good Manufacturing Practices, achieving International acclaim and recognition soon after its incorporation. The company remained a major supplier to the Federal Supply Services, Government of U.S.A, The British Crown Agents, the United Nations, various international relief agencies besides exporting to many developed countries including Australia, Iran, Hong Kong, Jordan, Saudi Arabia, Singapore, Sri Lanka, Sudan, Tanzania, Thailand, Turkey and the U.A.E.
The company has a long and highly successful history of collaborations with various multinational companies in the past, including Boots Pharmaceuticals PLC of U.K, Chemie Grunenthal GmbH, Germany, Lakeside laboratories U.S.A, Orgasynth Laboratories of France and Proctor & Gamble, U.S.A.
Now the company has expanded its portfolio of medical solutions for critical diseases by forging alliances with some of the world’s most innovative companies including Gilead Sciences, Inc., a global leader in the treatment of HIV and Viral Hepatitis, the Boston Scientific Corporation, USA the world’s leading manufacturer of medical devices, and a joint venture in biopharmaceuticals with the Bagó Group of Argentina. We also have partnerships with BioGaia of Sweden for a line of probiotics as well as Performance Health, Inc. USA for the brand, Biofreeze pain relief products.
